16-year-old girl survives stroke caused by 'unusually stubborn blood clot'
It was once vanishingly rare for a teenager to have a stroke. It was once extremely rare for a blood clot causing a stroke to be unresponsive to any of the typical treatments designed to dissolve the clot. Yet a 16-year-old girl who recently survived a stroke is far from being the only such case in recent years.
A tumor that isn't cancer — what could cause that?
The story as reported in the media began during class when the girl suddenly began to feel numb and then lost all feeling and power of movement in the right side of her body. Her speech became slurred; alarmed school staff had her rushed to the hospital where an urgent MRI scan revealed a blockage in an artery in her brain.
Doctors attempting to utilize the usual methods of clearing the blockage described it as “unusually stubborn and resistant to conventional stroke catheterization techniques.” Eventually, they were forced to implant a stent during a four-hour-long brain surgery.
During surgery, it was discovered that the carotid artery was “blocked at its origin.” Following the operation, the girl was therefore transferred for further tests which revealed a huge mass, described by media as a “tumor,” on the girl’s mitral valve in her heart. The tumor was so large that it had started to break up which seemed to explain the stroke, as one part of it had apparently made its way to the carotid artery.
The girl then underwent heart surgery to remove this tumor and thankfully seems to be making a good recovery.
16-year-olds having strokes — what could cause that?
One of the doctors involved in the girl’s case described the unusual nature of what he saw:
This is an extremely rare case, seeing such a severe stroke in a young, healthy girl. Stroke cases of this kind are more commonly seen in patients aged 60 to 70. It’s exceedingly rare in a 16-year-old, especially with a heart tumor involved.
He also noted that treatment was unusually difficult, offering no suggestion as to why this might have been the case:
The brain catheterization was very complex and required a series of intricate and precise steps to open the artery without damaging it. During the catheterization, we consulted with neurology and imaging teams to ensure the best approach for opening the blockage.
The most important thing is that the girl has returned to herself. She could have suffered severe disability or even death, but thankfully, her recovery seems complete, and we expect her to return to a full routine over time.
Three years ago, a similar story reached the media of a 16-year-old teenage boy who, like the girl in the recent case, had been “completely healthy.” Completely healthy, that is, until he received a COVID shot. The girl’s vaccination status has not been disclosed in media reports.
The boy “developed a large blood clot in the carotid artery.” In further parallels to the girl’s case, conventional treatment for blood clots failed to resolve his situation and eventually he had to undergo emergency surgery to have the clot removed.
Blood clots? Or...
Calling these arterial blockages “blood clots” is possibly misleading, according to many physicians and others who have seen these clots and handled them. In fact, most of the little that is known about these clots comes from embalmers rather than doctors, who are less vulnerable to pressure to keep quiet about what they are seeing. Doctors, by contrast, face loss of their professional reputation and even their medical license if they take a step too far, as Dr. Ryan Cole, a once-highly regarded pathologist, discovered when he began revealing what he found in autopsy patients.
Embalmers such as John O'Looney from the UK and Richard Hirschman from the US have, however, risked censure by speaking out and even publishing pictures of these “blood clots” that are so tough and fibrous that they resist normal methods of clearing out the vascular system that allow embalmers to inject the preservative fluids they use.
Despite the professional risks, some doctors are also beginning to speak out not only regarding finding such clots upon autopsy, but also on removing them from patients who survive the experience.
COVID may be just like flu. But the vaccines are not the same at all
How common are these clots, and how dangerous are they?
A recent study set out to answer a similar question and discovered that clots found in the brain are 112,000 percent more likely to occur following COVID vaccination than after the influenza vaccine. Compared to other vaccines, the COVID shot is 20,700 percent more likely to lead to a brain clot.
This study was published in the International Journal of Innovative Research in Medical Science on November 1, 2024, and was authored by Dr. Peter A. McCullough and others. The researchers used data from VAERS, the federal government's post-vaccination reporting system, taken from 1990 through 2023 relating to cerebral thromboembolism (CTE).
They found that in the three years since the COVID shots have been rolled out, there have been 5137 CTE adverse events reported to VAERS in relation to COVID shots, as opposed to just 52 related to flu shots and 282 for all other vaccines.
It was also noted that the incidence of post-COVID-vaccine CTE was significantly higher in women than men, by a ratio of 1.63:1.
Senior cardiologists: Stop the shots, now!
The researchers concluded that given the alarming data emerging from the data, US authorities should immediately suspend all use of COVID vaccines:
There is an alarming breach in the safety signal threshold concerning cerebral thrombosis AEs after COVID-19 vaccines compared to that of the influenza vaccines and even when compared to that of all other vaccines.
An immediate global moratorium on the use of COVID-19 vaccines is necessary with an absolute contraindication in women of reproductive age.
Is a study of two million people conclusive enough?
Dr. McCullough was once one of the world’s most respected cardiologists. Like Dr. Cole, he has seen his reputation in mainstream medicine reduced to tatters due to his audacity in opposing the prevailing COVID narrative. In recent years, he has authored numerous studies highlighting the dangers of the COVID vaccines. Another study he led was recently published and followed two million people in King County, Washington. It, too, revealed startling safety signals.
Around 98 percent of King County residents received at least one shot of a COVID vaccine. Dr. McCullough’s study, published in the Journal of Emergency Medicine, compared excess cardiopulmonary deaths before and after the COVID shots were introduced and found a significant increase over the past four years.
Around 600,000 King County residents had confirmed COVID infections, and the number of excess cardiopulmonary arrests did increase markedly during the first year of COVID, before the vaccines were introduced. However, in the years following vaccine uptake, the rate of excess fatal cardiopulmonary arrests continued to rise and did so even more sharply than before.
Excess fatal cardiopulmonary arrests were estimated to have increased by 1,236% from 2020 to 2023, rising from 11 excess deaths in 2020 to 147 excess deaths in 2023.
The study noted that extrapolating these figures to the entire country suggests that almost 50,000 excess cardiopulmonary deaths have occurred following the introduction of COVID vaccines:
Applying our model from these data to the entire United States yielded 49,240 excess fatal cardiopulmonary arrests from 2021-2023.
COVID may be bad for your heart; COVID vaccines are much worse
This study also examined the number of cardiopulmonary-related calls made to emergency services and found that the numbers rose significantly following the roll-out of the COVID shots. Many of these patients died despite receiving prompt medical treatment.
EMS deaths were found to have increased by 20 percent in 2020 as compared to the years between 2017 and 2019. Following the introduction of the COVID vaccines, the numbers jumped even more, up by 37 percent from 2017-9. And a year later, in 2022, the numbers were still rising with rates 54 percent higher than in the pre-COVID era.
The study’s authors concluded:
We identified a significant … association between excess fatal cardiopulmonary arrests and the COVID-19 vaccination campaign. The increase in excess cardiopulmonary arrest deaths may also be attributed to COVID-19 infection and disruptions in emergency care during the pandemic.
Urgent further research is needed to confirm our observations with attention to risk mitigation for incident events and improved survival with resuscitation.
Study had same findings in 2022 — who listened?
Based on previous experience, it seems unlikely that such further research will be undertaken unless government policy changes significantly. Two years ago, in 2022, a study based on countrywide data from Israel showed very similar findings and the study’s authors made similar albeit more cautious recommendations — which were not adopted.
This study was published in Nature and examined all EMS cardiac-related calls made between 14 months prior to the COVID era until after the vaccines were introduced for all adults over the age of 16.
The researchers were particularly concerned about their findings for younger age groups as they discovered that the number of EMS calls related to either CA (cardiac arrest) or ACS (acute coronary syndrome) increased by over 25 percent for people aged 16 to 39 after the vaccines were introduced.
The main finding of this study concerns increases of over 25% in both the number of CA calls and ACS calls of people in the 16–39 age group during the COVID-19 vaccination rollout in Israel (January–May, 2021), compared with the same period of time in prior years (2019 and 2020).
In fact, the vaccine uptake and the uptick in EMS calls was found to be closely correlated:
Moreover, there is a robust and statistically significant association between the weekly CA and ACS call counts, and the rates of 1st and 2nd vaccine doses administered to this age group.
When the researchers examined the pre-vaccine period, when COVID was spreading swiftly among the population, they discovered no such correlation:
At the same time there is no observed statistically significant association between COVID-19 infection rates and the CA and ACS call counts.
And they noted that researchers in Scotland and Germany had made similar findings:
This result is aligned with previous findings which show increases in overall CA incidence were not always associated with higher COVID19 infections rates at a population level.
Sudden and 'unexplained' death?
In their conclusions, the researchers pointed to the known risk of myocarditis following COVID vaccination and suggested that some cases of myocarditis might have been misdiagnosed as ACS and that people whose myocarditis went undiagnosed due to lack of symptoms might have died from cardiac arrest:
The large increase in the incidence of CA and ACS events in the population of age 16–39 parallel to the vaccination rollout and its association with the vaccination rates could be consistent with the known causal relationship between the mRNA vaccines and incidents of myocarditis in young people, as well as the fact that myocarditis is often misdiagnosed as ACS, and that asymptomatic myocarditis is a frequent cause for unexplained sudden death among young adults from CA.
And they also noted the same discrepancy between the ways in which males and females responded to the vaccines:
While vaccine-induced myocarditis was predominantly reported in males it is interesting to note that the relative increases of CA and ACS events was larger in females.
The study’s authors concluded with an appeal for vaccine side-effects to be closely monitored with a view to investigating their causes, and for people to be made aware of the warning signs that could make the difference between a patient being treated in time by doctors knowing what they were dealing with, and a fatal outcome:
Second, it is essential to raise awareness among patients and clinicians with respect to related symptoms (e.g., chest discomfort and shortness of breath) following vaccination or COVID-19 infection to ensure that potential harm is minimized. This is especially important among the younger population and particularly young females, who often receive less diagnostic evaluation for adverse cardiac events compared to males.
